Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
CGBD Transcript
Carlyle Secured Lending Inc. (CGBD) Q4 2025 Earnings Call Transcript
Positive2-25
The earnings call highlights several positive factors: increased deal flow, a sustainable dividend policy, capital structure optimization, and strategic team expansion. The Q&A section reveals a strong competitive advantage and resilient borrowing demand. Despite some markdowns in software investments, overall credit quality is stable. The SCP JV and share repurchases add to the positive outlook. The sentiment is bolstered by strategic initiatives and accretive share repurchases, suggesting a likely positive stock price movement.
Carlyle Secured Lending Inc. (CGBD) Q3 2025 Earnings Call Transcript
Unknown11-5
The earnings call presents a mixed picture: stable investment income and improved credit performance are positive, but increased expenses and potential earnings troughs are concerning. The Q&A reveals management's focus on defensive strategies and long-term growth via JVs, but uncertainties in spread compensation and the lack of compelling opportunities for second lien debt are negative. Overall, the sentiment is neutral, as positives and negatives balance out, with no immediate catalysts for strong stock price movement.
Carlyle Secured Lending Inc. (CGBD) Q2 2025 Earnings Call Transcript
Positive8-6
The earnings call indicates growth through strategic mergers, increased investments, and successful restructuring, reducing nonaccruals. While unrealized losses due to credit issues are a concern, management's optimism about future opportunities and strong deal flow, along with stable dividends, suggest a positive outlook. The Q&A reveals no major negative sentiment, and management's cautious approach to stock buybacks and joint ventures aligns with their growth focus. Overall, the sentiment leans positive, predicting a 2% to 8% stock price increase.
Carlyle Secured Lending Inc. (CGBD) Q1 2025 Earnings Call Transcript
Unknown5-7
The earnings call reveals several concerns, including increased non-accruals, declining NAV, and rising interest expenses. Despite a strategic merger and investment-grade ratings, financial performance is hindered by tight market spreads and economic risks. The Q&A section highlights management's uncertainty regarding dividend support and leverage targets, adding to investor apprehension. While the dividend yield is attractive, the lack of a share repurchase program and unclear management responses contribute to a negative sentiment. The combination of these factors suggests a likely negative stock price movement in the near term.
CGBD Slides
CGBD Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
